Last reviewed · How we verify
BaidI Quzhi granule — Competitive Intelligence Brief
phase 3
Traditional Chinese Medicine / Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
BaidI Quzhi granule (BaidI Quzhi granule) — Shanghai Yueyang Integrated Medicine Hospital. BaidI Quzhi granule is a traditional Chinese medicine formulation designed to improve blood circulation and remove blood stasis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BaidI Quzhi granule TARGET | BaidI Quzhi granule | Shanghai Yueyang Integrated Medicine Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BaidI Quzhi granule CI watch — RSS
- BaidI Quzhi granule CI watch — Atom
- BaidI Quzhi granule CI watch — JSON
- BaidI Quzhi granule alone — RSS
Cite this brief
Drug Landscape (2026). BaidI Quzhi granule — Competitive Intelligence Brief. https://druglandscape.com/ci/baidi-quzhi-granule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab